Dual immune checkpoint inhibition with radiotherapy does not improve progression-free survival for patients with newly diagnosed MGMT-unmethylated glioblastoma
NRG Oncology recently reported the results of the National Cancer Institute-sponsored phase II/III NRG-BN007 clinical…